DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
53	シェーグレン症候群	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00637793 (ClinicalTrials.gov)	February 2008	11/3/2008	Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome	A Double-Blind, Placebo-Controlled, Cross Over Study Using a Latin Square Design to Evaluate the Safety, Tolerability, and Efficacy of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjogren's Syndrome	Xerostomia;Sjogren's Syndrome	Drug: NGX267	TorreyPines Therapeutics	NULL	Completed	21 Years	55 Years	Both	24	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00637793
(ClinicalTrials.gov)

February 2008

11/3/2008

Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome

A Double-Blind, Placebo-Controlled, Cross Over Study Using a Latin Square Design to Evaluate the Safety, Tolerability, and Efficacy of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjogren's Syndrome

Xerostomia;Sjogren's Syndrome

Drug: NGX267

TorreyPines Therapeutics

NULL

Completed

21 Years

55 Years

Both

Phase 2

United States